Erica Sutter has a passion for learning. Over the course of her career as an antitrust and patent litigator, she has turned this passion into a powerful asset for gaining the detailed knowledge of new technologies and industries necessary to best advocate for her clients. Recent areas of focus in Erica’s practice include pharmaceuticals, medical devices, data analytics, direct-to-consumer retail, telecommunications, and health insurance.
Erica has substantial experience in all phases of trial court litigation, as well as at the appellate level. Her antitrust experience includes representing clients in merger litigation, class action price-fixing litigation, antitrust challenges arising out of settlement agreements from prior pharmaceutical patent cases, and during regulatory agencies’ “second requests.” Her patent litigation experience focuses on pharmaceuticals and involves representing clients both in district court litigation and proceedings before the United States Patent Trial and Appeal Board. Erica also regularly offers her clients strategic counseling on general antitrust and patent considerations. By maintaining an active antitrust and patent practice, Erica is well positioned to help clients navigate the issues that occur at the cross-roads of these two areas of law.
Prior to joining Fenwick, Erica was an associate in the global competition and antitrust group of a leading international law firm. She also previously worked at bio-fabrication startup Modern Meadow. During law school, she was an editor for both the Santa Clara Law Review and the Santa Clara High Technology Journal. As an undergraduate, Erica was involved in research relating to stem cells, including induced pluripotent stem cells, at North Carolina State University College of Veterinary Medicine and at the University College London. More recently, she completed her Master of Animal Science degree at North Carolina State University, where she specifically sought out courses on topics such as metabolism, regulatory affairs of pharmaceutical products, neurobiology, and cancer biology in order to better understand her clients’ industries.